New York, NY, April 10, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Monoclonal Antibody Therapeutics Market by Application (Cancer, Autoimmune Diseases, Infection, Hematological Diseases, and Others), By Source and By End Users: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2023”. According to the report, global monoclonal antibody therapeutics market was valued at approximately USD 108.01 billion in 2017 and is expected to generate revenue of around USD 218.97 billion by the end of 2023, growing at a CAGR of around 12.5% between 2017 and 2023.

Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins. This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells. The commercial development of therapeutic monoclonal antibodies commenced in the early 1980s, and by 1986 the first therapeutic monoclonal antibody was approved for prevention of kidney transplant rejection.

Browse through 54 Tables & 29 Figures spread over 110 Pages and in-depth TOC on "Global Monoclonal Antibody Therapeutics Market Size, Share, Types, Analysis and Forecast 2017 – 2023”.

Download Free Brochure of Global Monoclonal Antibody Therapeutics Market Report @ https://www.zionmarketresearch.com/requestbrochure/monoclonal-antibody-therapeutics-market

The monoclonal antibody therapeutics market is segmented on the basis of application into cancer, autoimmune diseases, infection, hematological diseases and others. The autoimmune disease segment is expected to dominate the global monoclonal antibody therapeutics market however the cancer segment is also expected to show higher growth due to increase in usage of monoclonal antibodies in treatment for cancer. Based on the source, the market is divided into a human, humanized, chimeric, and others. The human antibody segment is anticipated to dominate the market. On the basis of the end user, the market is divided into hospitals, private clinics, and research institutes. Research institute segment is expected to dominate the global monoclonal antibody therapeutics market in the forecast period whereas there is significant growth in hospital segment due to the rising use of the monoclonal antibody in the treatment of various diseases in hospitals.

North America is expected to dominate the global monoclonal antibody therapeutics market. This is due to the rapid acceptance of the monoclonal antibody product and increasing adaption of therapeutic antibodies for treatment. Increase in the research and development activities fuels the growth of this market in North America. Rising awareness about the monoclonal antibody therapeutics among the physicians as well as the patients has also fueled the growth of the market.

Request Free Sample Copy of Research Report @ https://www.zionmarketresearch.com/sample/monoclonal-antibody-therapeutics-market

Europe is the second largest regional market and is expected to show significant growth in the years to come due to the increase in the prevalence of cancer and other auto immunological diseases. Many pharmaceutical companies and government funding for the research of the monoclonal antibody therapeutics has driven the market in Europe.

Asia Pacific is expected to witness rapid growth during the forecast years. The market is driven due to increase in the aging population, the expiry of the patents of key biologicals, increasing disposable income and supporting legislation by the government. Rise in initiatives by the government for the use of monoclonal antibodies in research and treatment purpose has also driven the growth of monoclonal antibody therapeutics market.

Browse the full "Monoclonal Antibody Therapeutics Market by Application (Cancer, Autoimmune Diseases, Infection, Hematological Diseases, and Others), By Source and By End Users: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2023" report at https://www.zionmarketresearch.com/report/monoclonal-antibody-therapeutics-market

The Middle East and Africa and Latin America are expected to witness the least growth in comparison to other regions. The anticipated economic improvement and enhancement in the technologies in these regions is expected to fuel the growth of the monoclonal antibody therapeutics market in the future.

Some of the key players in the global monoclonal antibody therapeutics market include Pfizer Inc., Bayer AG, Sanofi, Merck & Co., Inc., GlaxoSmithKline Plc., F. Hoffmann-La Roche Ltd., Novartis AG, and AbbVie Inc. 

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/monoclonal-antibody-therapeutics-market

This report segments the global monoclonal antibody therapeutics market as follows:

Global Monoclonal Antibody Therapeutics Market: Application Segment Analysis

  • Cancer
  • Autoimmune Diseases
  • Infection
  • Hematological Diseases
  • Others

Global Monoclonal Antibody Therapeutics Market: Source Segment Analysis

  • Human
  • Humanized
  • Chimeric
  • Others

Global Monoclonal Antibody Therapeutics Market: End-User Segment Analysis

  • Hospitals
  • Private Clinics
  • Research Institute

Global Monoclonal Antibody Therapeutics Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Blog: http://industryresearchnews.com | http://www.e-marketresearch.com | http://marketglobalnews.com  | http://theindustrytoday.com  | https://detroitnews24.com  | http://thebookofkindle.com

Contact Us:

Joel John

244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com